Serial 88153553
Live / Registered — Registered — partial Section 8 accepted (as of 20 Nov 2025)
What this means for you
Registered since 20 Aug 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88153553
- Registration number
- 5838045
- Mark type
- Design / logo
- Filed
- 12 Oct 2018
- Published for opposition
- 04 Jun 2019
- Registered
- 20 Aug 2019
- Attorney of record
- Roberto Ledesma
Goods and services
- Class 001 — Chemicals: Chemicals for scientific, medical and industrial research purposes, as well as cells for scientific and research use; Cell culture media and cultures of microorganisms, all other than for medical or veterinary use
- Class 005 — Pharmaceuticals: [ Cell cultures with human cells, in particular cryopreserved pluripotent stem cells for medical or veterinary use; Cell culture systems comprised of human cells, in particular crypreserved pluripotent stem cells for medical or veterinary use ]
- Class 042 — Scientific and technological services: Scientific and industrial research in the chemical, biological and biochemical sectors; Services of chemical, biological and biochemical laboratories
Owner
- NCARDIA B.V., LEIDEN, NL
- Ncardia AG, Cologne, DE
- Ncardia AG, Cologne, DE
- Ncardia AG, Cologne, DE
Prosecution history
- 20 Nov 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 20 Nov 2025 — REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED
- 17 Nov 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 18 Jul 2025 — TEAS SECTION 8 RECEIVED
- 20 Aug 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 09 Dec 2020 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 20 Aug 2019 — REGISTERED-PRINCIPAL REGISTER
- 04 Jun 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 04 Jun 2019 — PUBLISHED FOR OPPOSITION
- 15 May 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 26 Apr 2019 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 26 Apr 2019 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 26 Apr 2019 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 25 Apr 2019 — ASSIGNED TO LIE
- 17 Apr 2019 — TEAS RESPONSE TO OFFICE ACTION RECEIVED